Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v20-FR Version v7-EN
Language French English
Date Updated 2021-01-26 2020-07-10
Drug Identification Number 02468913 02468913
Brand name APO-DABIGATRAN APO-DABIGATRAN
Common or Proper name DABIGATRAN DABIGATRAN
Company Name APOTEX INC APOTEX INC
Ingredients DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE
Strength(s) 150MG 150MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60 BTL 60 BTL
ATC code B01AE B01AE
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-04-06 2020-04-06
Estimated end date 2021-01-22 2020-09-04
Actual end date 2021-01-22
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments